| Cas No.: | 331771-20-1 |
| Chemical Name: | ZM-447439 |
| Synonyms: | N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide;ZM 447439;ZM-447439;N-(4-((6-Methoxy-7-(3-Morpholinopropoxy)quinazolin-4-yl)aMino)phenyl)benzaMide;N-(4-(6-methoxy-7-(3-morpholinopropoxy)quinazolin-4-ylamino)phenyl)benzamide;ZM447439 (ZM-447439);BenzaMide, N-[4-[[6-Methoxy-7-[3-(4-Morpholinyl)propoxy]-4-quinazolinyl]aMino]phenyl]- |
| SMILES: | O=C(NC1=CC=C(NC2=C(C(C=C3OCCCN4CCOCC4)=NC=N2)C=C3OC)C=C1)C5=CC=CC=C5 |
| Formula: | C29H31N5O4 |
| M.Wt: | 513.58754 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | ZM447439 (ZM) is a potent and selective inhibitor of aurora-A and -B kinase with putative anti-tumoral activity. ZM induced apoptosis in a concentration- and time-dependent manner. For the detailed information about the solubility of ZM447439 (ZM-447439) in water, the solubility of ZM447439 (ZM-447439) in DMSO, the solubility of ZM447439 (ZM-447439) in PBS buffer, the animal experiment（test） of ZM447439 (ZM-447439),the in vivo,in vitro and clinical trial test of ZM447439 (ZM-447439),the cell experiment（test） of ZM447439 (ZM-447439),the IC50, EC50 and Affinity of ZM447439 (ZM-447439), please contact DC Chemicals. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|